161 related articles for article (PubMed ID: 27762214)
1. Bullous pemphigoid in infancy with spontaneous remission.
Nomura H; Funakoshi T; Baba A; Tanikawa A; Hayakawa K; Amagai M
Eur J Dermatol; 2017 Feb; 27(1):95-96. PubMed ID: 27762214
[No Abstract] [Full Text] [Related]
2. Sensitivities and utility of non-invasive serological tests in the diagnosis of bullous pemphigoid.
Yew YW; Tey HL
Int J Dermatol; 2016 Sep; 55(9):e510-1. PubMed ID: 27028937
[No Abstract] [Full Text] [Related]
3. Possible correlation of IgE autoantibody to BP180 with disease activity in bullous pemphigoid.
Kamiya K; Aoyama Y; Noda K; Miyake T; Yamaguchi M; Hamada T; Tokura Y; Iwatsuki K
J Dermatol Sci; 2015 Apr; 78(1):77-9. PubMed ID: 25771164
[No Abstract] [Full Text] [Related]
4. Circulating IgE anti-BP180 autoantibody and its correlation to clinical and laboratorial aspects in bullous pemphigoid patients.
Ma L; Wang M; Wang X; Chen X; Zhu X
J Dermatol Sci; 2015 Apr; 78(1):76-7. PubMed ID: 25797173
[No Abstract] [Full Text] [Related]
5. Autoantibody serum levels and intensity of pruritus in bullous pemphigoid.
Bardazzi F; Barisani A; Magnano M; Tengattini V; La Placa M; Patrizi A; Balestri R
Eur J Dermatol; 2016 Aug; 26(4):390-1. PubMed ID: 27210833
[No Abstract] [Full Text] [Related]
6. Anti-desmogleins autoantibodies detected by ELISA and blotting in bullous pemphigoid: what do they mean?
Julio T; Vernal S; Turatti A; Roselino AM
Int J Dermatol; 2018 Jan; 57(1):124-127. PubMed ID: 29152717
[No Abstract] [Full Text] [Related]
7. Elevated levels of circulating immunoglobulin E autoantibodies against BP180 and BP230 in an intractable case of bullous pemphigoid.
Akasaka E; Hagiwara C; Takiyoshi N; Aizu T; Nakano H; Sawamura D; Ota T
J Dermatol Sci; 2016 Oct; 84(1):110-113. PubMed ID: 27492811
[No Abstract] [Full Text] [Related]
8. Bullous pemphigoid induced by pembrolizumab in a patient with advanced melanoma expressing collagen XVII.
Wada N; Uchi H; Furue M
J Dermatol; 2017 Oct; 44(10):e240-e241. PubMed ID: 28677843
[No Abstract] [Full Text] [Related]
9. Detection of anti-BP180 NC16A autoantibodies after the onset of dipeptidyl peptidase-IV inhibitor-associated bullous pemphigoid: a report of three patients.
Mai Y; Nishie W; Izumi K; Yoshimoto N; Morita Y; Watanabe M; Toyonaga E; Ujiie H; Iwata H; Fujita Y; Nomura T; Sato-Matsumura KC; Shimizu S; Shimizu H
Br J Dermatol; 2018 Sep; 179(3):790-791. PubMed ID: 29624639
[No Abstract] [Full Text] [Related]
10. Pustular psoriasis associated with bullous pemphigoid with fluctuating anti-BP180 antibody titre according to the condition of pustular lesions.
Otani Y; Hayashi S; Kaneko Y; Koike M; Gommori T; Hamasaki Y; Igawa K
Eur J Dermatol; 2021 Feb; 31(1):107-109. PubMed ID: 33648907
[No Abstract] [Full Text] [Related]
11. Erythema With Nonscarring, Tense Blister Formation Without Circulating Anti-BP180 Antibodies.
Otake-Irie H; Dainichi T; Kabashima K
JAMA Dermatol; 2017 Nov; 153(11):1185-1186. PubMed ID: 28636686
[No Abstract] [Full Text] [Related]
12. Biological and Clinical Response to Omalizumab in a Patient with Bullous Pemphigoid.
Menzinger S; Kaya G; Schmidt E; Fontao L; Laffitte E
Acta Derm Venereol; 2018 Feb; 98(2):284-286. PubMed ID: 29136264
[No Abstract] [Full Text] [Related]
13. Discovery of a patient with strongly suspected bullous pemphigoid in a ward by oral health care providers.
Kanda N; Soga Y; Meguro M; Tanabe A; Yagi Y; Himuro Y; Fujiwara Y; Takashiba S; Kobayashi N
Int J Dent Hyg; 2011 May; 9(2):159-62. PubMed ID: 21356008
[TBL] [Abstract][Full Text] [Related]
14. Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid.
Kamata M; Asano Y; Shida R; Maeda N; Yoshizaki A; Miyagaki T; Kawashima T; Tada Y; Sato S
J Dermatol; 2019 Jun; 46(6):e216-e217. PubMed ID: 30628103
[No Abstract] [Full Text] [Related]
15. Case of atypical bullous pemphigoid with generalized pruritus and eczema as the prodrome for 10 years.
Ikeda T; Okamoto K; Furukawa F
J Dermatol; 2012 Aug; 39(8):720-1. PubMed ID: 22011062
[No Abstract] [Full Text] [Related]
16. Detection and characterization of IgG, IgE, and IgA autoantibodies in patients with bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors.
Fania L; Salemme A; Provini A; Pagnanelli G; Collina MC; Abeni D; Didona B; Di Zenzo G; Mazzanti C
J Am Acad Dermatol; 2018 Mar; 78(3):592-595. PubMed ID: 28987492
[No Abstract] [Full Text] [Related]
17. Elevated IL-31 serum levels in bullous pemphigoid patients correlate with eosinophil numbers and are associated with BP180-IgE.
Salz M; Haeberle S; Hoffmann J; Enk AH; Hadaschik EN
J Dermatol Sci; 2017 Sep; 87(3):309-311. PubMed ID: 28823642
[No Abstract] [Full Text] [Related]
18. Bullous pemphigoid of infancy - report and review of infantile and pediatric bullous pemphigoid.
Ferreira BR; Vaz AS; Ramos L; Reis JP; Gonçalo M
Dermatol Online J; 2017 Feb; 23(2):. PubMed ID: 28329498
[TBL] [Abstract][Full Text] [Related]
19. Erythema Multiforme-Like Bullous Pemphigoid.
Imbernón-Moya A; Aguilar A; Burgos F; Gallego MÁ
Actas Dermosifiliogr; 2016 Oct; 107(8):689-91. PubMed ID: 27048923
[No Abstract] [Full Text] [Related]
20. A case of childhood bullous pemphigoid with IgG and IgA autoantibodies to various domains of BP180.
Osawa M; Ueda-Hayakawa I; Isei T; Yoshimura K; Fukuda S; Hashimoto T; Okamoto H
J Am Acad Dermatol; 2014 Jun; 70(6):e129-31. PubMed ID: 24831331
[No Abstract] [Full Text] [Related]
[Next] [New Search]
